TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods August 12, 1977
TCL Archive In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR December 2, 1977